| Literature DB >> 10632058 |
V R Atigadda1, W J Brouillette, F Duarte, Y S Babu, S Bantia, P Chand, N Chu, J A Montgomery, D A Walsh, E Sudbeck, J Finley, G M Air, M Luo, G W Laver.
Abstract
Neuraminidase (NA) plays a critical role in the life cycle of influenza virus and is a target for new therapeutic agents. A new benzoic acid inhibitor (11) containing a lipophilic side chain at C-3 and a guanidine at C-5 was synthesized. The X-ray structure of 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid in complex with NA revealed that the lipophilic side chain binds in a newly created hydrophobic pocket formed by the movement of Glu 278 to interact with Arg 226, whereas the guanidine of 11 interacts in a negatively charged pocket created by Asp 152, Glu 120 and Glu 229. Compound 11 was highly selective for type A (H2N2) influenza NA (IC50 1 microM) over type B (B/Lee/40) influenza NA (IC50 500 microM).Entities:
Mesh:
Substances:
Year: 1999 PMID: 10632058 DOI: 10.1016/s0968-0896(99)00197-2
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641